Maravai Lifesciences Holdings Inc (MRVI) — Cash Flow Quality Index
Maravai Lifesciences Holdings Inc (MRVI) has a Cash Flow Quality Index of 1.14x as of December 2022. Operating cash flow of $99.33 Million exceeds net income of $87.43 Million, indicating high earnings quality where cash backs reported profits. Explore Maravai Lifesciences Holdings Inc (MRVI) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Maravai Lifesciences Holdings Inc Cash Flow Quality Index (2020–2022)
Historical Cash Flow Quality Index for Maravai Lifesciences Holdings Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Maravai Lifesciences Holdings Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Maravai Lifesciences Holdings Inc (2020–2022)
Year-by-year earnings quality comparison for Maravai Lifesciences Holdings Inc. For live market cap and the full company financial profile, see MRVI market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 1.09x | $535.98 Million | $490.66 Million | ▲ +39.1% |
| 2021 | 0.79x | $368.57 Million | $469.25 Million | ▼ -59.3% |
| 2020 | 1.93x | $152.19 Million | $78.82 Million | — |